All
RSSArticles
-
Managing Appendicitis Medically
A multicenter, randomized trial showed that 10 days of antibiotics results in comparable outcomes as surgery. Three in 10 patients treated with antibiotics required surgery within 90 days.
-
Patients with Higher Renin Levels May Derive More Benefit from Angiotensin II Treatment
Serum renin concentration in patients with catecholamine-resistant vasodilatory shock may identify those for whom treatment with angiotensin II has improved intensive care unit outcomes.
-
Convalescent Plasma Therapy Does Not Affect Time to Clinical Improvement in Patients with Severe and Life-Threatening COVID-19
This was a randomized, open-label, multicenter trial of intravenous convalescent plasma infusion (4 mL/kg to 13 mL/kg) therapy. Convalescent plasma therapy was not associated with improvements in mortality or time to clinical improvement.
-
A Review of Current Therapeutics for Severe COVID-19 Pneumonia
The aim of this special feature is to review therapeutic options for hospitalized patients with COVID-19 pneumonia.
-
Novel COVID-19 Syndrome in Adults
Healthcare workers could be at risk of multisystem inflammatory syndrome linked to COVID-19, as the poorly understood condition, first seen in children, now is emerging in adults.
-
Are Healthcare Workers Exposing Colleagues to COVID-19?
Healthcare workers may be vigilant with personal protective equipment (PPE) around COVID-19 patients, but inadvertently expose colleagues when they take breaks, socialize, and eat.
-
Coronavirus Vaccine Hesitancy in Black and Latinx Communities
Historically, minority populations have been victimized in medical research. People of color and ethnic minorities generally are at risk of more serious outcomes if infected with SARS-CoV-2.
-
CDC: COVID’s Worst Is Yet to Come
The COVID-19 pandemic is coming to a disastrous boiling point in the United States, with one of the nation’s top public health officials predicting a high death toll as the pandemic surges nationwide over the winter months.
-
Healthcare Workers Cleared for COVID-19 Shots, Long-Term Care Residents Raise Safety Concerns
A Centers for Disease Control and Prevention advisory panel finalized COVID-19 vaccine priority for healthcare workers and long-term care residents, although the latter received the greenlight only after discussions of safety concerns that led to the one dissenting vote in a 13-1 approval.
-
FDA Approves Pfizer Vaccine for COVID-19
The Food and Drug Administration’s vaccine advisory committee has approved the use of the COVID-19 vaccine developed by Pfizer Inc. (NYC) and BioNTech (Mainz, DEU) in the United States for those ages 16 years and older. The first doses will go to healthcare workers and long-term care residents.